132 related articles for article (PubMed ID: 3925442)
21. [Studies of pyrazine derivatives. VI. Synthesis and tuberculostatic activity of 6-alkoxy and 6-phenoxy pyrazine-2-carbothioamides].
Foks H; Janowiec M
Acta Pol Pharm; 1978; 35(2):143-7. PubMed ID: 96662
[No Abstract] [Full Text] [Related]
22. Studies on pyrazine derivatives. Part VII. Synthesis and tuberculostatic activity of some pyrazine amidines and amidoximes.
Foks H; Janowiec M
Pol J Pharmacol Pharm; 1977; 29(1):61-8. PubMed ID: 404633
[TBL] [Abstract][Full Text] [Related]
23. [Studies of pyrazine derivatives. XVII. Synthesis and the tuberculostatic activity of pyrazinyl-1,3,4-oxadiazole derivatives].
Pancechowska-Ksepko D; Foks H; Landowska E; Janowiec M; Zwolska-Kwiek Z
Acta Pol Pharm; 1986; 43(2):116-23. PubMed ID: 3096080
[No Abstract] [Full Text] [Related]
24. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
Pavlov EP
Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
[No Abstract] [Full Text] [Related]
25. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
Grumbach F; Rist N
Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
[No Abstract] [Full Text] [Related]
26. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
27. Studies on pyrazine derivatives--XXXIV. Synthesis and tuberculostatic activity of alpha-oxo ketene dithioacetals pyrazine derivatives.
Milczarska B; Foks H; Mikołajczyk K; Janowiec M; Zwolska Z; Andrzejczyk Z
Acta Pol Pharm; 2000; 57(4):307-10. PubMed ID: 11126620
[TBL] [Abstract][Full Text] [Related]
28. Studies on pyrazine derivatives, XXIX: Synthesis of N1-thioamido substituted pyrazincarboxyamidrazones with expected tuberculostatic activity.
Orlewska C; Foks H; Janowiec M; Zwolskakwiek Z
Pharmazie; 1995 Aug; 50(8):565-6. PubMed ID: 7568322
[No Abstract] [Full Text] [Related]
29. [Antitubercular properties of erythromycin A cyclic 11,12-carbonate in experiments in vitro and in vivo].
Janowiec M; Marczewska J; Stambrowska A; Bojarska-Dahlig H
Pol Tyg Lek; 1985 May; 40(21):604-7. PubMed ID: 3927273
[No Abstract] [Full Text] [Related]
30. Shortening the treatment of tuberculosis.
Mitchison DA
Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
[No Abstract] [Full Text] [Related]
31. [Studies of pyrazine derivatives. XXV. Synthesis and the tuberculostatic activity of the products of reaction of 5-(6-methoxy- and 5-(6 morpholinopyrazinyl)-1,3,4-oxadiazol-2-thione with amines].
Pancechowska-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
Acta Pol Pharm; 1988; 45(5):373-9. PubMed ID: 3150245
[No Abstract] [Full Text] [Related]
32. Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents.
Prado S; Ledeit H; Michel S; Koch M; Darbord JC; Cole ST; Tillequin F; Brodin P
Bioorg Med Chem; 2006 Aug; 14(15):5423-8. PubMed ID: 16616504
[TBL] [Abstract][Full Text] [Related]
33. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
Belogurova VP; Gorislavets II; Ivanitskaia NN
Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
[No Abstract] [Full Text] [Related]
34. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
Sriram D; Yogeeswari P; Reddy SP
Bioorg Med Chem Lett; 2006 Apr; 16(8):2113-6. PubMed ID: 16464574
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of patients excreting multi-resistant Mycobacterium tuberculosis in the sputum].
Gomi J; Konno K; Oizumi K; Fukuhara T; Kudo S
Kekkaku; 1970 May; 45(5):10-4. PubMed ID: 4991801
[No Abstract] [Full Text] [Related]
37. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives.
Ghosh S; Tiwari P; Pandey S; Misra AK; Chaturvedi V; Gaikwad A; Bhatnagar S; Sinha S
Bioorg Med Chem Lett; 2008 Jul; 18(14):4002-5. PubMed ID: 18579372
[TBL] [Abstract][Full Text] [Related]
38. Preclinical testing of new drugs for tuberculosis: current challenges.
Lenaerts AJ; Degroote MA; Orme IM
Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
[TBL] [Abstract][Full Text] [Related]
39. [Mechanism of action "in vitro" and "in vivo" of antitubercular drugs].
Gialdroni-Grassi G
G Ital Chemioter; 1966; 13(1):11-26. PubMed ID: 4967319
[No Abstract] [Full Text] [Related]
40. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis].
Xu G; Li H; Liu S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
